Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRACES feasibility study in gestational diabetes
2013-004706-25Phase 4Completed
- Sponsor
- University of Edinburgh
- Start
- Apr 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in gestational diabetes mellitus (GDM) comparing Metformin + glibenclamide with Metformin + insulin (standard care) (2 arms). Primary endpoint: Recruitment feasibility. Started Apr 2014; status: completed.
02
Drugs
glibenclamidemetforminhuman insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2013-004706-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004706-25.